Company Chairman and CEO Alex Gorsky said the acquisition of Synthes contributed to the company’s first quarter success. The company’s overall orthopedics sales reached $2.3 billion in the first quarter, a 59 percent increase. Sales in the United States increased 61 percent in 2013.
More Articles on Orthopedic Devices:
MAKO Surgical Acquires Stanmore Robotic Assets
Titan Spine Presents Data to Support Endoskeleton Implant for Lumbar Fusion
Medtronic Spine to Reduce Workforce, Cut Costs by 5%
Johnson & Johnson’s 1Q Orthopedics Sales Up 59%
DePuy Synthes Spine parent company Johnson & Johnson reported the acquisition of Synthes and subsequent divestiture of the DePuy trauma business contributed to a 5.7 percent worldwide operational sales growth in the first quarter of 2013.
